Literature DB >> 17653097

The field of cancer research: an indicator of present transformations in biology.

M Morange1.   

Abstract

'Biology and cancer research have developed together. Invariably, at each stage, the characteristics of the cancer cell have been ascribed to some defect in whatever branch of biology happens at the time to be fashionable and exciting; today, it is molecular genetics'. Tremendous transformations have occurred in cancer research since these few lines were written by John Cairns: the discovery of oncogenes and anti-oncogenes, and the successful development of 'magic bullets' targeting the proteins encoded by these oncogenes. Nevertheless, Cairns' message is still valid. In 1978, he observed the first attempts to apply the tools and concepts of molecular biology to cancer; today, this research field reflects multiple and diverse efforts that go 'beyond' molecular biology by looking for explanations that have been left aside during its development, or by privileging new approaches, fully original or actively pursued in other fields of biological research. Because of this specific characteristic of cancer research, it is possible to use it as an indicator of trends in biological research in general.

Entities:  

Mesh:

Year:  2007        PMID: 17653097     DOI: 10.1038/sj.onc.1210583

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

Review 1.  Multi-functional nanocarriers to overcome tumor drug resistance.

Authors:  Lara S Jabr-Milane; Lilian E van Vlerken; Sunita Yadav; Mansoor M Amiji
Journal:  Cancer Treat Rev       Date:  2008-06-05       Impact factor: 12.111

2.  Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+ cellular models of breast cancer.

Authors:  Yogesh M Kulkarni; David J Klinke
Journal:  Proteome Sci       Date:  2012-02-22       Impact factor: 2.480

3.  CD133 is a marker of bioenergetic stress in human glioma.

Authors:  Corinne E Griguer; Claudia R Oliva; Eric Gobin; Pascale Marcorelles; Dale J Benos; Jack R Lancaster; G Yancey Gillespie
Journal:  PLoS One       Date:  2008-11-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.